The Information Services Department at The Children's Hospital of Philadelphia is being recognized for developing an innovative technology that will improve patient care.

CHOP researchers used synthetic peptides to treat two serious genetic blood diseases, beta-thalassemia and polycythemia vera, in animal models.

Salon l’Etoile Jenkintown treated patients with facial differences to a day of pampering.

Tasian, a pediatric urologist at CHOP, was recognized for his dedicated research and commitment to treating pediatric kidney stone disease.

CHOP experts contributed to the Resilience Project—detecting people who are protected from their own gene mutations that usually cause severe childhood diseases.

Everything you need to know about ear tubes: from how to know if your child needs them, to what to expect after surgery and longer term.

CHOP and Penn scientists used a drug candidate to prevent multiple bone problems in animals with the human mutation for a rare but debilitating genetic disease.

Wondering if your child could be sensitive to gluten or benefit from a gluten-free diet? We asked Ritu Verma, MBChB, director of CHOP’s Center for Celiac Disease, for help in recognizing the signs of a gluten sensitivity.

CHOP occupational therapists will be visiting CHOP campus locations April 11 – 15 to share information about OT and to highlight the importance of this service to our patients. Look for the signs if you are interested in participating!

CHOP researchers identified a new syndrome that causes intellectual disability. They suggest that an amino acid supplement may treat this condition in the future.